Trump’s HHS Nominee Got A Sweetheart Deal From A Foreign Biotech Firm
Category: POLITICS
Tom Price's stock deals resurrect concerns about powerful public officials gaining investment opportunities unavailable to the public.
By Kaiser Health News, 2017-01-16